Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01213238
Title Hepatic Arterial Infusion Oxaliplatin, Capecitabine With or Without Bevacizumab
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

Advanced Solid Tumor

Therapies

Oxaliplatin

Capecitabine

Bevacizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.